Novavax Estrasorb
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
A June NDA submission is planned for the estrogen replacement cream. Novavax entered a co-promotion agreement with King Pharmaceuticals Jan. 8 to share U.S. marketing expenses and revenues for Estrasor
A June NDA submission is planned for the estrogen replacement cream. Novavax entered a co-promotion agreement with King Pharmaceuticals Jan. 8 to share U.S. marketing expenses and revenues for Estrasorb |